![intrado-vector-logo-small](https://painqx.com/wp-content/uploads/2021/06/intrado-vector-logo-small.png)
PainQx Awarded $1.5 M Phase II SBIR Contract from the Defense Health Agency
June 9, 2021
NEW YORK, NY- – PainQx, Inc. (www.painqx.com), a medical device company developing a next-generation approach to objectively assess chronic pain, is pleased to announce it has been awarded a Defense Health Agency (www.health.mil) Phase II SBIR contract. The DHA SBIR contract will enable PainQx to refine and expand the capabilities of its novel pain assessment technology, the ALGOS System.
![Sc-600](https://painqx.com/wp-content/uploads/2019/12/Sc-600.jpg)
PainQx Accepted to the Digital Health Accelerator
September 28, 2017
PHILADELPHIA–(September 26, 2017) – Flushable pregnancy tests, remote patient monitoring systems, augmented reality to prepare for emergency situations – these are among the seven technologies being developed by the third class of the University City Science Center’s Digital Health Accelerator (DHA).
![MABA-logo](https://painqx.com/wp-content/uploads/2020/01/MABA-logo.jpg)
Mid Atlantic Bio Angels Invests in PainQx
September 11, 2017
NEW YORK, Sept. 08, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in New York and Philadelphia-based PainQx, Inc., which has developed an accurate and objective method to measure chronic and acute pain in humans.